HEPION PHARMACEUTICALS, INC. Accrued Employee Benefits, Current
HEPION PHARMACEUTICALS, INC. (HEPA) had Accrued Employee Benefits, Current of $3.30 million as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2023-05-12
- 2023-03-31: Accrued Employee Benefits, Current $3.30M.
- 2022-12-31: Accrued Employee Benefits, Current $1.90M.
- 2022-09-30: Accrued Employee Benefits, Current $2.20M.
- 2022-06-30: Accrued Employee Benefits, Current $2.20M.
| Period end | Accrued Employee Benefits, Current |
|---|---|
| 2023-03-31 | $3.30M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.90M 10-K · filed 2023-04-10 |
| 2022-09-30 | $2.20M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.20M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.60M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.60M 10-K · filed 2022-04-08 |
| 2021-09-30 | $900.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $600.00K 10-Q · filed 2021-08-16 |
| 2020-06-30 | $400.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |